Navigation Links
Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

SCHLIEREN (Zurich), Switzerland, July 3, 2007 - Cytos Biotechnology AG (SWX:CYTN) announced today results from a phase IIa study with CYT003-QbG10 in atopic dermatitis. CYT003-QbG10 is an immunotherapeutic product candidate currently in development for the treatment of allergic diseases. The present study aimed to assess safety, tolerability and exploratory efficacy of the product candidate in a new indication, namely atopic dermatitis. The study was designed as a placebo-controlled, randomized and double-blind trial in 36 patients suffering from mild to moderate atopic dermatitis (AD). Exploratory efficacy was determined according to the Eczema Area and Severity Index (EASI), a commonly applied test to assess the extent and severity of AD.

Treatment with CYT003-QbG10 was safe and generally well tolerated. In both the placebo-treated and CYT003-QbG10-treated groups a similar reduction of the EASI scores was measured over the study period indicating no treatment effect for CYT003-QbG10 in atopic dermatitis at the dose level tested in this trial.

Dr. Wolfgang Renner, CEO of Cytos Biotechnology, commented: “While CYT003-QbG10 has shown strong efficacy in conjunction with a specific allergen in patients with house dust mite allergy, we are still in the process of identifying the best treatment parameters for its application as a monotherapy. This monotherapy has achieved first promising results in grass pollen and also house dust mite allergy. For the latter indication we are now testing higher doses of the product candidate. Based on the outcome of these studies we will then also consider the path forward in atopic dermatitis.”

About the phase IIa study
The randomized, double-blind and placebo-controlled phase IIa study included 36 male and female patients aged 18 to 65 and suffering from mild to moderate AD. Upon entry into the study, the extent and severity of the disease was assessed by the Eczema Area Severit
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis
2. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
3. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
9. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:4/21/2015)... -- A groundbreaking new, minimally invasive outpatient treatment option ... is now readily available to the estimated 1 million ... who suffer from this condition. ... leading practitioner of this safe, effective, Federal Drug Administration-approved ... new Los Angeles -area medical centers ...
(Date:4/21/2015)... -- Oxfordshire -based ... doubled its overseas sales in just 4 years. ... Queen,s Award for Enterprise, for Outstanding Achievement in International ... Communications consultancy, helping its clients bring new medicines to ... than doubled its exports in just 4 years, from ...
(Date:4/21/2015)... , April 21, 2015 Cardiologists at Henry ... of stroke in patients with an irregular heartbeat. ... procedure, Henry Ford is able to add another ... atrial fibrillation, which affects the heart,s ability to pump. ... and first-ever commercial Watchman implant at a non-clinical ...
Breaking Medicine Technology:New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 2New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 4Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) disclosed today ... (HCV) infected patients with the Aethlon Hemopurifier® will be ... of the American Society of Nephrology (ASN). Dr. Vijay ... of Nephrology at the Fortis Hospital in New Delhi, ...
... LAUSANNE, Switzerland, October 15 Biocartis ... molecular and,immunodiagnostics based on its proprietary micro-technology platform, today,announced ... round. The,Company raised EUR 10 million ( USD 14.9 ... The deal was led by ...
Cached Medicine Technology:Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference 2Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference 3Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3
(Date:4/21/2015)... Emphasizing the need for a commonsense, ... (NACDS) lauded U.S. House passage of bipartisan legislation today ... patients in need of medications. H.R. 471, the ... of 2015 now moves one step closer to ... prescription drug abuse, addiction and face challenges accessing much-needed ...
(Date:4/21/2015)... 2015 Patients seeking surgical treatment for ... choice for receiving treatment at a nationally accredited program ... quality of care in the greater Tampa area. ... center has been accredited as a Comprehensive Center under ... Program (MBSAQIP), a joint program of the American College ...
(Date:4/21/2015)... FL (PRWEB) April 21, 2015 ... will honor Dina Tyler, Felton Institute’s Coordinator of ... and Recovery in Early Psychosis) Program in Alameda ... Excellence: Peer Specialist of the Year Award at ... the Oscars of behavioral health. , The Inspiring ...
(Date:4/21/2015)... April 21, 2015 On April 2, ... Trying to Achieve Kylie Jenner Lips With ... have injured themselves while attempting an at-home lip ... Twitter is that creating an airlock around one’s mouth ... to plump and achieve Kylie Jenner’s now famous pout. ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 22, 2015 ... Pipeline Review, H1 2015” provides comparative analysis ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report with TOC ... , The report also reviews key players ...
Breaking Medicine News(10 mins):Health News:House Passage of Bipartisan Bill to Prevent Abuse and Preserve Access Lauded by NACDS 2Health News:House Passage of Bipartisan Bill to Prevent Abuse and Preserve Access Lauded by NACDS 3Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 2Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 3Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 4Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... Park have discovered that Normal Human Bronchial Epithelial (NHBE) ... the high end of plasma zinc attainable by oral ... arrest and DNA damage-induced gene (Gadd45) mRNA and protein ... research, published in the March 08 issue of the ...
... METAIRIE, La., Feb. 25 AT&T Inc. (NYSE: ... contract with Louisiana-based,LAMMICO, a preferred insurer dedicated to ... physicians and other health,care providers., Under terms ... Network,(VPN) services to LAMMICO,s four domestic locations; three ...
... and customer relations, FARMINGTON HILLS, Mich., Feb. ... laser hair removal and other noninvasive,aesthetic services in ... Huis as the company,s chief revenue officer., ... for generating profitable,revenues for the organization and driving ...
... Acuo Technologies is a market,leading provider of comprehensive ... collaboration and migration services. Recently,there has been an ... the,increasing size of digital imaging archives caused by ... onset of new contributors,like digital pathology systems. Many ...
... Brings New Enterprise Intelligence Systems and Services to ... ... #1841 --,Harris Corporation (NYSE: HRS ) today unveiled a new ... wide variety of,medical and patient information in operating room environments and ...
... for Using Wireless ... of Patient Care, WALTHAM, Mass., Feb. 25 ... (WLANs) for enterprises and,service providers, will leverage its participation ... February 24-28 in Orlando, FL, to,showcase how the company,s ...
Cached Medicine News:Health News:High zinc status in lung cells slows growth and induces DNA damage-induced gene expression 2Health News:High zinc status in lung cells slows growth and induces DNA damage-induced gene expression 3Health News:AT&T Enhances Performance for LAMMICO With Upgraded Network Services 2Health News:AT&T Enhances Performance for LAMMICO With Upgraded Network Services 3Health News:American Laser Centers Names Bill Van Huis as Chief Revenue Officer 2Health News:Acuo Technologies(R) Offers Free Migration Archive License 2Health News:Acuo Technologies(R) Offers Free Migration Archive License 3Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 2Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 3Health News:Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
This large 1000 L tip makes pipetting fragile cells, genomic DNA, and viscous samples easy. Perfect for cell culture laboratories....
300 L, Bulk Recommended for 250 and 300 L pipettes....
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
Medicine Products: